Jove
Visualize
Contact Us

Related Concept Videos

Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial.

Annals of internal medicine·2010
Same author

Reducing the incidence and severity of herpes zoster and PHN with zoster vaccination.

The Journal of the American Osteopathic Association·2009
Same author

A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses.

Journal of medical virology·2009
Same author

Preventing herpes zoster through vaccination.

Ophthalmology·2008
Same journal

Summary of the 6th International Conference on HHV-6 and -7.

Herpes : the journal of the IHMF·2009
Same journal

Case report and literature review: HHV-6-associated meningoencephalitis in an immunocompetent adult.

Herpes : the journal of the IHMF·2009
Same journal

Importance of chromosomally integrated HHV-6A and -6B in the diagnosis of active HHV-6 infection.

Herpes : the journal of the IHMF·2009
Same journal

The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease.

Herpes : the journal of the IHMF·2009
Same journal

Provocation and progress.

Herpes : the journal of the IHMF·2009
Same journal

Treatment for Epstein-Barr virus-associated PTLD.

Herpes : the journal of the IHMF·2009
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 24, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Varicella zoster virus redux.

Lawrence D Gelb1

  • 1Washington University School of Medicine, St Louis, MO 63110, USA. ldgelb@swbell.net

Herpes : the Journal of the IHMF
|March 25, 2009
PubMed
Summary
This summary is machine-generated.

The varicella zoster vaccine is recommended for adults over 60 to prevent herpes zoster. Available data suggests physicians should not consider this vaccine to be of marginal value.

More Related Videos

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
07:27

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Related Experiment Videos

Last Updated: Jun 24, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
07:27

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Area of Science:

  • Immunization Practices
  • Virology
  • Public Health

Background:

  • The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommended the varicella zoster vaccine for adults over 60 in 2008.
  • This live-attenuated vaccine aims to prevent and reduce the severity of herpes zoster (shingles).

Purpose of the Study:

  • To review available data on the efficacy and value of the varicella zoster vaccine.
  • To address the misconception among some physicians regarding the vaccine's marginal utility.

Main Methods:

  • Review of existing scientific literature and clinical data on the varicella zoster vaccine.
  • Analysis of recommendations from the Advisory Committee on Immunization Practices.

Main Results:

  • The varicella zoster vaccine is recommended for routine administration in adults aged 60 and above.
  • Available data supports the vaccine's significant value in preventing and attenuating herpes zoster.

Conclusions:

  • Physicians' perception of the varicella zoster vaccine's marginal value is not supported by current evidence.
  • The varicella zoster vaccine is a valuable tool for preventing herpes zoster in older adults.